FI900412A0 - Antiviral eller antibakteriell foerening och foerfarande foer anvaendning daerav. - Google Patents

Antiviral eller antibakteriell foerening och foerfarande foer anvaendning daerav.

Info

Publication number
FI900412A0
FI900412A0 FI900412A FI900412A FI900412A0 FI 900412 A0 FI900412 A0 FI 900412A0 FI 900412 A FI900412 A FI 900412A FI 900412 A FI900412 A FI 900412A FI 900412 A0 FI900412 A0 FI 900412A0
Authority
FI
Finland
Prior art keywords
antiviral
antibakteriell
foerening
eller
foerfarande foer
Prior art date
Application number
FI900412A
Other languages
English (en)
Finnish (fi)
Inventor
Witold Kiczka
Original Assignee
Nika Health Care Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nika Health Care Inc filed Critical Nika Health Care Inc
Publication of FI900412A0 publication Critical patent/FI900412A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
FI900412A 1988-05-26 1990-01-25 Antiviral eller antibakteriell foerening och foerfarande foer anvaendning daerav. FI900412A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17858888A 1988-05-26 1988-05-26
PCT/US1988/001785 WO1989011294A1 (fr) 1988-05-26 1988-05-26 Compose antiviral ou antibacterien et procede d'utilisation
OA59731A OA09785A (en) 1988-05-26 1990-01-26 Antiviral or antibacterial compound and method of use

Publications (1)

Publication Number Publication Date
FI900412A0 true FI900412A0 (fi) 1990-01-25

Family

ID=33162813

Family Applications (1)

Application Number Title Priority Date Filing Date
FI900412A FI900412A0 (fi) 1988-05-26 1990-01-25 Antiviral eller antibakteriell foerening och foerfarande foer anvaendning daerav.

Country Status (23)

Country Link
US (3) US5200182A (fr)
EP (1) EP0380484B1 (fr)
JP (1) JPH0649659B2 (fr)
AT (1) ATE93143T1 (fr)
AU (1) AU624331B2 (fr)
BG (1) BG60544B1 (fr)
CA (1) CA1335425C (fr)
CS (1) CS277030B6 (fr)
DK (1) DK173078B1 (fr)
ES (1) ES2011577A6 (fr)
FI (1) FI900412A0 (fr)
HK (1) HK42394A (fr)
HU (1) HU204710B (fr)
IL (1) IL90092A (fr)
LV (1) LV10054B (fr)
MA (1) MA21560A1 (fr)
MW (1) MW390A1 (fr)
OA (1) OA09785A (fr)
PH (1) PH26284A (fr)
RU (1) RU2092183C1 (fr)
WO (1) WO1989011294A1 (fr)
YU (1) YU109289A (fr)
ZA (1) ZA893382B (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU624331B2 (en) * 1988-05-26 1992-06-11 Nika Health Products Ltd. A composition having as its active ingredient lysozyme or ribonuclease dimer in a pharmaceutically acceptable carrier
RU2067617C1 (ru) * 1990-01-08 1996-10-10 Ника Хелт Продактс Лтд. Способ получения димера лизоцима
US5989880A (en) 1990-01-08 1999-11-23 Nika Health Products Ltd. Method of preparing lysozyme dimers
PL173978B1 (pl) * 1992-07-13 1998-05-29 Nika Health Products Ltd Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej
CH682541A5 (de) * 1992-06-23 1993-10-15 Urs Viktor Dr Wirth Biochemische Inaktivierung von RNA-Viren.
US6183742B1 (en) 1992-07-13 2001-02-06 Nika Health Products, Limited Applications of lysozyme dimer
DZ1964A1 (fr) * 1995-01-13 2002-10-15 Nika Health Products Ltd Nouvelle applications d'un dimère de lysozyme.
GB2304048A (en) * 1995-08-12 1997-03-12 John William Carson Medicament containing saliva extract
US6123937A (en) * 1997-03-14 2000-09-26 Nika Health Products, Limited Applications of lysozyme dimer
US6716813B2 (en) * 2000-11-28 2004-04-06 House Ear Institute Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
US7338936B2 (en) * 2000-11-28 2008-03-04 House Ear Institute Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
JP2002187853A (ja) * 2000-12-21 2002-07-05 Shinei Ferumentekku:Kk 動物の乳頭除菌剤および菌環境改善方法
DE10210285A1 (de) * 2002-03-08 2003-11-13 Medigene Ag Reversibles Toxin und seine Verwendung
JP2008505853A (ja) * 2004-04-13 2008-02-28 クインテセンス バイオサイエンシーズ インコーポレーティッド 細胞傷害性薬剤としての非天然のリボヌクレアーゼ複合体
US20050244402A1 (en) * 2004-04-30 2005-11-03 Villanueva Julie M Absorption of pain-causing agents
US7348301B2 (en) * 2006-02-16 2008-03-25 Buckman Laboratories International, Inc. Lysozyme-based method and composition to control the growth of microorganisms in aqueous systems
JP2009541333A (ja) * 2006-06-23 2009-11-26 クインテセンス バイオサイエンシーズ インコーポレーティッド 修飾リボヌクレアーゼ
JP2009543868A (ja) 2006-07-17 2009-12-10 クインテセンス バイオサイエンシーズ インコーポレーティッド 癌治療に関する方法および組成物
WO2008109401A2 (fr) * 2007-03-02 2008-09-12 Saint Simeon Lda Composition et procédé de traitement du virus de papillome et des sarcoïdes équins
US20100317677A1 (en) * 2007-09-11 2010-12-16 Hassel Bret A Methods of Treating a Microbial Infection by Modulating RNase-L Expression and/or Activity
CA2702043A1 (fr) * 2007-10-08 2009-04-16 Quintessence Biosciences, Inc. Compositions et procedes pour des therapies a base de ribonuclease
JP2012504423A (ja) 2008-10-01 2012-02-23 クインテッセンス バイオサイエンシズ，インコーポレーテッド 治療用リボヌクレアーゼ
WO2010099182A1 (fr) * 2009-02-25 2010-09-02 Board Of Regents Of The University Of Nebraska Créatine activée et ses précurseurs en tant qu'agents antibactériens, compositions et produits les contenant et leurs utilisations
NZ600269A (en) 2009-05-20 2014-02-28 Dec Int Nz Ltd Delivery device for treatment of mastitis
EP2457576B1 (fr) 2010-11-29 2020-07-08 Eurochit Danuta Kruszewska Lactobacillus reuteri pour l'utilisation dans la prophylaxie et le traitement médical et vétérinaire du syndrome métabolique ou des infections.
RU2548803C2 (ru) * 2011-11-28 2015-04-20 Общество с ограниченной ответственностью " Фарматренд" ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ДЛЯ ЛЕЧЕНИЯ ГЛАЗНЫХ ИНФЕКЦИЙ P. Aeruginosa, СОДЕРЖАЩАЯ РЕКОМБИНАНТНЫЙ ЛИЗОЦИМ
RU2509801C2 (ru) * 2012-03-22 2014-03-20 Борис Михайлович Куриненко СПОСОБ ИСПОЛЬЗОВАНИЯ РИБОНУКЛЕАЗЫ Bacillus intermedius
EP2674162A1 (fr) 2012-05-29 2013-12-18 Danuta Kruszewska Nano-produit, comprenant des lactobacillus reuteri dan080, utile dans la prophylaxie, diagnostic et traitement médical et vétérinaire
CN104684565A (zh) 2012-05-29 2015-06-03 达努塔·克鲁谢夫斯卡 在人类和兽医的预防和医疗中有用的、包含罗伊氏乳杆菌dan080的纳米产品及其医疗用途
RU2504397C1 (ru) * 2012-10-25 2014-01-20 Леонид Леонидович Клопотенко Фармацевтическая композиция, содержащая фермент рибонуклеазу и глицирризиновую кислоту или ее соли: глицирризинат аммония, или дикалия, или тринатрия
US9950075B2 (en) 2013-03-15 2018-04-24 The University Of Massachusetts Compositions and methods for delivering agents to the central nervous system
US9573980B2 (en) 2013-03-15 2017-02-21 Spogen Biotech Inc. Fusion proteins and methods for stimulating plant growth, protecting plants from pathogens, and immobilizing Bacillus spores on plant roots
CN106029089B (zh) * 2014-02-21 2020-12-29 丘比株式会社 诺如病毒灭活剂及其制造方法
SG11201700611TA (en) * 2014-07-31 2017-02-27 Kewpie Corp Water-containing fluid composition, method for producing same, processed lysozyme and/or salt thereof, and method for producing same
NZ767896A (en) 2014-09-17 2024-01-26 Spogen Biotech Inc Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria
LV15071B (lv) * 2015-07-14 2016-02-20 Rīgas Stradiņa Universitāte Kompozīcija subklīniska mastīta ārstēšanai govīm
RU2634264C1 (ru) * 2016-09-19 2017-10-24 Александр Ливиевич Ураков Крем-молочко для лечения опоясывающего лишая
JP6547915B2 (ja) 2016-12-28 2019-07-24 Dic株式会社 分散体及びそれを用いたインクジェット用インク組成物、光変換層、及び液晶表示素子
WO2021021765A1 (fr) * 2019-07-26 2021-02-04 Evolve Biosystems, Inc. Compositions nutritives contenant des protéines bioactives

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1268M (fr) * 1961-06-29 1962-04-24 Puiseux Médicament antimitotique et antiviral.
FR4020M (fr) * 1965-01-29 1966-03-21
DE1517751C3 (de) * 1965-07-08 1975-02-27 Eisai Co., Ltd., Tokio Verfahren zum Verhindern der Bildung von flockigen Lysozym- und/oder Lysozymsalzniederschlägen in wässrigen Lösungen, die Lysozym und/oder Lysozymsalze enthalten
DE1545644A1 (de) * 1965-12-06 1969-08-07 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen quaternaeren Scopolammoniumsalzen
GB1110504A (en) * 1966-03-18 1968-04-18 Prodotti Antibiotici Spa Pharmaceutical compositions
US4221794A (en) * 1979-06-21 1980-09-09 Newport Pharmaceuticals International, Inc. Method of imparting immunomodulating and antiviral activity
US4510144A (en) * 1981-08-26 1985-04-09 Newport Pharmaceuticals International Methods of imparting immunomodulating activity with dihydrothiazolo purine derivatives
CA1263378A (fr) * 1985-01-08 1989-11-28 Robert James Alaimo Imidazo¬4,5-f|quinoleines, utiles comme agents immunomodulateurs
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
US4744984A (en) * 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
AU624331B2 (en) * 1988-05-26 1992-06-11 Nika Health Products Ltd. A composition having as its active ingredient lysozyme or ribonuclease dimer in a pharmaceutically acceptable carrier

Also Published As

Publication number Publication date
DK16890D0 (da) 1990-01-22
LV10054A (lv) 1994-05-10
ES2011577A6 (es) 1990-01-16
MW390A1 (en) 1990-11-14
ZA893382B (en) 1991-01-30
WO1989011294A1 (fr) 1989-11-30
HU883981D0 (en) 1990-12-28
US6099835A (en) 2000-08-08
RU2092183C1 (ru) 1997-10-10
US5466449A (en) 1995-11-14
PH26284A (en) 1992-04-10
CS277030B6 (en) 1992-11-18
IL90092A (en) 1995-03-30
AU1940888A (en) 1989-12-12
YU109289A (en) 1991-08-31
JPH0649659B2 (ja) 1994-06-29
JPH03504121A (ja) 1991-09-12
LV10054B (en) 1995-02-20
AU624331B2 (en) 1992-06-11
HUT54060A (en) 1991-01-28
BG60544B1 (en) 1995-08-28
HK42394A (en) 1994-05-13
CA1335425C (fr) 1995-05-02
DK173078B1 (da) 1999-12-20
HU204710B (en) 1992-02-28
EP0380484A1 (fr) 1990-08-08
US5200182A (en) 1993-04-06
EP0380484B1 (fr) 1993-08-18
CS318089A3 (en) 1992-05-13
OA09785A (en) 1994-04-15
DK16890A (da) 1990-01-22
MA21560A1 (fr) 1989-12-31
ATE93143T1 (de) 1993-09-15

Similar Documents

Publication Publication Date Title
FI900412A0 (fi) Antiviral eller antibakteriell foerening och foerfarande foer anvaendning daerav.
PT90465A (pt) Processo de preparacao de derivados da guanina imuno-estimulantes e de composicoes farmaceuticas que os contem
YU47543B (sh) Postupak za dobijanje farmaceutskog preparata za stimulaciju granulocita
CA2068324A1 (fr) Compositions peptidiques renfermant un metal et methodes de stimulation de la croissance des cheveux
PT911033E (pt) Utilizacao do interferao de consenso para a reducao dos efeitos secundarios do tratamento com interferoes na hepatite viral
PT90464A (pt) Processo de preparacao de derivados da guanina imuno-estimulantes e de composicoes farmaceuticas que os contem
KR950700333A (ko) 개량된 알파 인터페론 조성물 및 인간 말초혈 백혈구로부터의 제조 방법(improved alpha interferon composition and method for its production from human peripheral blood leukocytes)
IT1232827B (it) Proteine biologicamente attive, formulazioni che le contengono e metodo per prepararle ed applicarle
EP0305551A3 (fr) Compositions pharmaceutiques pour l'application topique
AU2840889A (en) Method of treating haematologic diseases and pharmaceutical compositions to be used therefor
DK0531413T3 (da) Et antiviralt præparat indeholdende prostratin
NO893135D0 (no) Fremgangsmaate for fremstilling av n-2,3-butadienyl tri- og tetraaminoalkanderivater.
AU3329293A (en) Method of imparting antimicrobial activity to an ophthalmic composition
ES2098455T3 (es) Compuestos de ciclohexapeptidil propanolamina.
ES2016464A6 (es) Procedimiento para preparar derivados de 2', 5' -oligoadenilato.
MY106984A (en) Antiviral or antibacterial composition and method of use.
GR1001006B (el) Μεθοδος παρασκευης και χρησιμοποιησεως αντιιικων η αντιβακτηριακων συνθεσεων.
PT86933A (pt) Process for the preparation pf optically active oxo-isoindolinyul derivatives and of pharmaceutical compositions containing the same
NO158186C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cis-2-(1h-imidazolylmethyl)-3-difluorbenzyloxy-2,3-dihydrofluorbenzo(b)thiofener.
GEP19971029B (en) Antiviral or antibacterial compound and method of use thereof
IT8348383A0 (it) Enzima simile a pepsina da leucocito umano, procedimento per prepararlo, e composizione terapeutica che lo contiene come ingrediente attivo
MX9307639A (es) Metodo para tratar infecciones virales con terapia conjuntiva con compuestos similares al aciclovir y un analogo de nucleosido 2'-viril substituido.
BE888313A (fr) Derives d'acides benzamioethylphenoxycyclohexylacetiques, leur procede de preparation et leur application en therapeutique,
FR2559485B2 (fr) Derives de pyrrolo-quinoline, leur preparation et leur application en therapeutique
FR2609029B1 (fr) Derives 5-aminoethyles de l'oxazolidinone-2, leur procede de preparation et leur application en therapeutique

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: NIKA HEALTH PRODUCTS, LTD.